• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的关键基因和趋同发病机制。

Key genes and convergent pathogenic mechanisms in Parkinson disease.

机构信息

Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Nat Rev Neurosci. 2024 Jun;25(6):393-413. doi: 10.1038/s41583-024-00812-2. Epub 2024 Apr 10.

DOI:10.1038/s41583-024-00812-2
PMID:38600347
Abstract

Parkinson disease (PD) is a neurodegenerative disorder marked by the preferential dysfunction and death of dopaminergic neurons in the substantia nigra. The onset and progression of PD is influenced by a diversity of genetic variants, many of which lack functional characterization. To identify the most high-yield targets for therapeutic intervention, it is important to consider the core cellular compartments and functional pathways upon which the varied forms of pathogenic dysfunction may converge. Here, we review several key PD-linked proteins and pathways, focusing on the mechanisms of their potential convergence in disease pathogenesis. These dysfunctions primarily localize to a subset of subcellular compartments, including mitochondria, lysosomes and synapses. We discuss how these pathogenic mechanisms that originate in different cellular compartments may coordinately lead to cellular dysfunction and neurodegeneration in PD.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是黑质中多巴胺能神经元的优先功能障碍和死亡。PD 的发病和进展受到多种遗传变异的影响,其中许多遗传变异缺乏功能特征。为了确定最有希望的治疗干预靶点,重要的是要考虑到各种形式的致病功能障碍可能汇聚的核心细胞区室和功能途径。在这里,我们回顾了几种与 PD 相关的关键蛋白和途径,重点讨论了它们在疾病发病机制中潜在汇聚的机制。这些功能障碍主要定位于包括线粒体、溶酶体和突触在内的亚细胞区室的一个子集。我们讨论了这些起源于不同细胞区室的致病机制如何协调导致 PD 中的细胞功能障碍和神经退行性变。

相似文献

1
Key genes and convergent pathogenic mechanisms in Parkinson disease.帕金森病的关键基因和趋同发病机制。
Nat Rev Neurosci. 2024 Jun;25(6):393-413. doi: 10.1038/s41583-024-00812-2. Epub 2024 Apr 10.
2
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.《拥挤的十字路口:帕金森病中线粒体、α-突触核蛋白与内溶酶体系统的相互作用》
Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312.
3
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
4
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.线粒体 DNA 缺失在多巴胺能神经元内的积累引发神经保护机制。
Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.
5
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.线粒体在帕金森病发病机制及治疗中的核心地位。
CNS Neurosci Ther. 2014 Jul;20(7):591-602. doi: 10.1111/cns.12264. Epub 2014 Apr 7.
6
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
7
Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review).线粒体介导的帕金森病多巴胺能神经元损伤(综述)。
Int J Mol Med. 2018 Feb;41(2):615-623. doi: 10.3892/ijmm.2017.3255. Epub 2017 Nov 16.
8
Parkinson's disease pathogenesis from the viewpoint of small fish models.从小鱼模型看帕金森病的发病机制。
J Neural Transm (Vienna). 2018 Jan;125(1):25-33. doi: 10.1007/s00702-017-1772-1. Epub 2017 Aug 2.
9
Parkinson's disease: From human genetics to clinical trials.帕金森病:从人类遗传学到临床试验
Sci Transl Med. 2015 Sep 16;7(305):205ps20. doi: 10.1126/scitranslmed.aaa8280.
10
Determinants of dopaminergic neuron loss in Parkinson's disease.帕金森病中多巴胺能神经元丧失的决定因素。
FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14.

引用本文的文献

1
Translating the Transcriptome: A Connectomics Approach for Gene-Network Mapping and Clinical Application.转录组翻译:一种用于基因网络映射和临床应用的连接组学方法
medRxiv. 2025 Aug 12:2025.08.08.25333301. doi: 10.1101/2025.08.08.25333301.
2
Proteomic insights into the biology of dopaminergic neurons.对多巴胺能神经元生物学的蛋白质组学见解。
Front Mol Neurosci. 2025 Jul 30;18:1642519. doi: 10.3389/fnmol.2025.1642519. eCollection 2025.
3
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.

本文引用的文献

1
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.多族裔帕金森病全基因组关联荟萃分析。
Nat Genet. 2024 Jan;56(1):27-36. doi: 10.1038/s41588-023-01584-8. Epub 2023 Dec 28.
2
The role of α-synuclein in exocytosis.α-突触核蛋白在胞吐作用中的作用。
Exp Neurol. 2024 Mar;373:114668. doi: 10.1016/j.expneurol.2023.114668. Epub 2023 Dec 24.
3
Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson's disease-linked LRRK2 kinase.全基因组筛选揭示Rab12 GTP酶是帕金森病相关LRRK2激酶的关键激活因子。
帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
4
Morphological profiling reveals neuroprotection via mitochondrial uncoupling in human dopaminergic neurons.形态学分析揭示了人类多巴胺能神经元中线粒体解偶联介导的神经保护作用。
Sci Rep. 2025 Aug 12;15(1):29507. doi: 10.1038/s41598-025-14735-0.
5
A Transcriptomic Roadmap of Parkinson's Disease Progression at Single Cell Resolution.单细胞分辨率下帕金森病进展的转录组学路线图
medRxiv. 2025 Jul 30:2025.07.30.25332436. doi: 10.1101/2025.07.30.25332436.
6
Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction.多巴胺与携带不同帕金森氏症突变的皮层神经元在溶酶体和线粒体功能障碍方面存在差异。
NPJ Parkinsons Dis. 2025 Jun 20;11(1):177. doi: 10.1038/s41531-025-01048-2.
7
The Role of 6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson's Disease.6-甲基腺嘌呤(m6A)RNA修饰在帕金森病发病机制中的作用
Biomolecules. 2025 Apr 23;15(5):617. doi: 10.3390/biom15050617.
8
COVID-19 Alters Inflammatory, Mitochondrial, and Protein Clearance Pathway Genes: Potential Implications for New-onset Parkinsonism in Patients.新冠病毒改变炎症、线粒体和蛋白质清除途径基因:对患者新发帕金森症的潜在影响
J Neuroimmune Pharmacol. 2025 May 22;20(1):58. doi: 10.1007/s11481-025-10215-4.
9
Autophagy in alzheimer disease pathogenesis and its therapeutic values.自噬在阿尔茨海默病发病机制中的作用及其治疗价值。
Autophagy Rep. 2025 May 8;4(1):2471677. doi: 10.1080/27694127.2025.2471677. eCollection 2025.
10
The role of dopaminergic medication and specific pathway alterations in idiopathic and -mediated Parkinson's disease.多巴胺能药物及特定通路改变在特发性和[此处原文似乎不完整,推测可能是“继发性”之类的词]帕金森病中的作用
Sci Adv. 2025 May 16;11(20):eadp7063. doi: 10.1126/sciadv.adp7063. Epub 2025 May 14.
Elife. 2023 Oct 24;12:e87098. doi: 10.7554/eLife.87098.
4
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.Rab12是LRRK2的调节剂,且其由受损溶酶体激活。
Elife. 2023 Oct 24;12:e87255. doi: 10.7554/eLife.87255.
5
Parkinson's disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons.帕金森病相关的 parkin 突变破坏了人多巴胺能神经元中突触囊泡的再循环。
Neuron. 2023 Dec 6;111(23):3775-3788.e7. doi: 10.1016/j.neuron.2023.08.018. Epub 2023 Sep 15.
6
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.在非洲和非洲混合人群中与帕金森病相关的遗传风险基因座和因果关系的鉴定:一项全基因组关联研究。
Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23.
7
PINK1 and Parkin regulate IPR-mediated ER calcium release.PINK1 和 Parkin 调节 IPR 介导的内质网钙释放。
Nat Commun. 2023 Aug 25;14(1):5202. doi: 10.1038/s41467-023-40929-z.
8
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition.LRRK2 通过 MiT-TFE 转录因子抑制抑制巨噬细胞和小神经胶质细胞中的溶酶体降解活性。
Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2303789120. doi: 10.1073/pnas.2303789120. Epub 2023 Jul 24.
9
Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson's disease.Parkin 在帕金森病中线粒体-溶酶体(M/L)接触部位调节氨基酸稳态。
Sci Adv. 2023 Jul 21;9(29):eadh3347. doi: 10.1126/sciadv.adh3347. Epub 2023 Jul 19.
10
PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems.PARK15/FBXO7 在 iNeurons 和 HeLa 细胞系统中对于 PINK1/Parkin 介导的线粒体自噬是可有可无的。
EMBO Rep. 2023 Aug 3;24(8):e56399. doi: 10.15252/embr.202256399. Epub 2023 Jun 19.